Peritoneal cancer vaccine (AVAX Technologies)

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NamePeritoneal cancer vaccine (AVAX Technologies)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsKidney Failure, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenDenmarkGermany +[5] 
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAvax Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFresenius Medical Care Deutschland Gmbh
Active IndicationsN/A
Inactive IndicationsKidney Failure, Chronic

Other Information

ATC CodeN/A
Related LinksN/A